Methyl-(1-propyl-naphthalen-2-ylmethyl)amine → (E)-3-[6-Amino-5-(4-methyl-piperazin-1-ylmethyl)pyridin-3-yl]-N-(2-ethoxy-3-methyl-benzyl)-N-methyl-acrylamide hydrochloride
Reaction equation
[ClH:1].[NH2:2][C:3]1[N:8]=[CH:7][C:6](/[CH:9]=[CH:10]/[C:11]([OH:13])=O)=[CH:5][C:4]=1[CH2:14][N:15]1[CH2:20][CH2:19][N:18]([CH3:21])[CH2:17][CH2:16]1.Cl.CN1[CH2:30][C:29]2[CH:31]=[C:32](/[CH:35]=[CH:36]/[C:37](O)=O)[CH:33]=[N:34][C:28]=2NC(=O)C1.C[C:42]1[C:43]([O:51]CC)=C(C=CC=1)CCN.CNCC1C=CC2C(=CC=CC=2)C=1CCC>>[ClH:1].[NH2:2][C:3]1[N:8]=[CH:7][C:6](/[CH:9]=[CH:10]/[C:11]([N:34]([CH2:33][C:32]2[CH:35]=[CH:36][CH:37]=[C:29]([CH3:30])[C:31]=2[O:51][CH2:43][CH3:42])[CH3:28])=[O:13])=[CH:5][C:4]=1[CH2:14][N:15]1[CH2:20][CH2:19][N:18]([CH3:21])[CH2:17][CH2:16]1Participants
Reactant 4
Product 1
Procedure
According to the procedure of Example 1, except substituting (E)-3-[6-amino-5-(4-methyl-piperazin-1-ylmethyl)pyridin-3-yl]acrylic acid hydrochloride for the (E)-3-(4-methyl-2-oxo-2,3,4,5-tetrahydro-1H-pyrido[2,3-e][1,4]diazepin-7-yl)acrylic acid hydrochloride, and substituting (3-methyl-2-ethoxy-benzyl)methylamine for the methyl-(1-propyl-naphthalen-2-ylmethyl)amine, the title compound (114 mg, 17%) was prepared as an off-white solid: 1H NMR (300 MHz, DMSO-d6) δ 8.42 (s, 1H), 8.33 (d, J=6.0 Hz, 1H), 8.13 (br s, 2H), 7.48 (dd, J=10.0, 5.1 Hz, 1H), 7.27 (d, J=9.3 Hz, 1H), 7.13 (dd, J=10.6, 4.4 Hz, 1H), 7.04-6.97 (m, 1H), 6.90-6.87 (m, 1H), 4.81-4.66 (m, 2H), 3.87-3.81 (m, 2H), 3.63-3.36 (m, 7H), 3.10-2.85 (m, 7H), 2.72 (s, 3H), 2.24 (s, 3H), 1.35 (t, J=4.2 Hz, 3H);
Sources & evidence
- ORD record
- ord-b20f6f04a556486ba33be1696612b40c
- Source dataset
- uspto-grants-2010_09
- Patent number
- US07790709B2
Reaction notes
Loading…